Volume 10, Issue 2 (Vol.10 No.2 Jul 2021)                   rbmb.net 2021, 10(2): 280-287 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Eshaghkhani Y, Mohamadifar A, Asadollahi M, Taghizadeh M, Karamzade A, Saberi M, et al . Whole-Exome Sequencing Identified a Novel Variant (C.405_422+39del) in DSP Gene in an Iranian Pedigree with Familial Dilated Cardiomyopathy. rbmb.net. 2021; 10 (2) :280-287
URL: http://rbmb.net/article-1-648-en.html
Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran & Watson Genetic Laboratory, North Kargar Street, Tehran, Iran.
Abstract:   (204 Views)
Background: Dilated cardiomyopathy (DCM) is a progressive heart condition characterized by left ventricular chamber enlargement associated with systolic heart failure and prolonged action potential duration. Genetic variations in genes that encode cytoskeleton, sarcomere, and nuclear envelope proteins are responsible for 45% of cases. In our study, we focused on a pedigree with familial DCM to decipher the potential genetic cause(s) in affected members developing arrhythmia, end-stage heart failure, and sudden death.

Methods: Whole-exome sequencing (WES) was exploited for a 27-year-old heart-transplanted female as the proband, and the derived data were filtered using the standard pipelines.

Results: A 57-nucleotide deletion (c.405_422+39del) in the desmoplakin gene (DSP) (NM_004415.4) was identified as a novel pathogenic variant. Familial segregation analysis indicated that this variant is present in clinically affected members and absent in unaffected members.

Conclusions: It seems that the detected variant induces intron retention, resulting in a premature stop codon in intron 3 of DSP leading to production of a truncated, nonfunctional protein. Additionally, it can trigger a nonsense-mediated mRNA decay pathway associated with inhibition of protein production. The present study results illustrated that a novel deletion in DSP can cause DCM in an Iranian family.
Full-Text [PDF 475 kb]   (106 Downloads)    
Type of Article: Case Report | Subject: Molecular Biology
Received: 2021/01/30 | Accepted: 2021/02/13 | Published: 2021/08/26

References
1. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23), 1850-8. [DOI:10.1093/eurheartj/ehv727] [PMID]
2. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. (2013). 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239.
3. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2),270-6. [DOI:10.1093/eurheartj/ehm342] [PMID]
4. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nature Reviews Cardiology. 2013;10(9):531-547. [DOI:10.1038/nrcardio.2013.105] [PMID]
5. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, D Arnett, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation. 2006;113(14):1807-16. [DOI:10.1161/CIRCULATIONAHA.106.174287] [PMID]
6. Long PA, Larsen BT, Evans JM, et al. Exome sequencing identifies pathogenic and modifier mutations in a child with sporadic dilated cardiomyopathy. J Am Heart Assoc. 2015;4(12):e002443. [DOI:10.1161/JAHA.115.002443] [PMID] [PMCID]
7. Piran S, Liu P, Morales A, Hershberger RE. (2012). Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure. J Am Coll Cardiol. 2012;60(4):283-9. [DOI:10.1016/j.jacc.2012.05.005] [PMID]
8. Semsarian C, MacDonald P, Weintraub RG. Dilated cardiomyopathy. Lancet. 2017;390(10092):400-414. [DOI:10.1016/S0140-6736(16)31713-5]
9. Japp AG, Gulati A, Cook SA, Martin R Cowie, Sanjay KP. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67(25):2996-3010. [DOI:10.1016/j.jacc.2016.03.590] [PMID]
10. Haas, J., Frese, K. S., Peil, B., et al. (2015). Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J. 2015;36(18):1123-35a.
11. McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017;121(7):731-748. [DOI:10.1161/CIRCRESAHA.116.309396] [PMID] [PMCID]
12. Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010;31(22):2715-26. [DOI:10.1093/eurheartj/ehq271] [PMID]
13. Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi V, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2002; 71(5):1200-6. [DOI:10.1086/344208] [PMID] [PMCID]
14. Elliott P. Diagnosis and management of dilated cardiomyopathy. Heart. 2000;84(1):106. [DOI:10.1136/heart.84.1.106] [PMID] [PMCID]
15. Hershberger R E, Morales A, Siegfried JD. (2010). Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med. 2010;12(11):655-67. [DOI:10.1097/GIM.0b013e3181f2481f] [PMID] [PMCID]
16. Mestroni L, Taylor M R. Genetics and genetic testing of dilated cardiomyopathy: a new perspective. Discov Med. 2013;15(80):43-9.
17. Majewski J, Schwartzentruber J, Lalonde E, Montpetit A, Jabado N, et al. What can exome sequencing do for you?. J Med Genet. 2011;48(9):580-9. [DOI:10.1136/jmedgenet-2011-100223] [PMID]
18. Norton N, Li D, Hershberger R E. (2012). Next-generation sequencing to identify genetic causes of cardiomyopathies. Curr Opin Cardiol. 27(3):214-20. [DOI:10.1097/HCO.0b013e328352207e] [PMID]
19. Smith E A, Fuchs E. Defining the interactions between intermediate filaments and desmosomes. J Cell Biol. 1998;141(5):1229-1241. [DOI:10.1083/jcb.141.5.1229] [PMID] [PMCID]
20. Garrod D, Chidgey M. Desmosome structure, composition and function. Biochim Biophys Acta. 2008;1778(3):572-87. [DOI:10.1016/j.bbamem.2007.07.014] [PMID]
21. Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigoet G, et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J. 2005;26(16):1666-75. [DOI:10.1093/eurheartj/ehi341] [PMID]
22. Rasmussen TB, Hansen J, Nissen PH, Dalager S, Jensen UB, Kim WY, et al. Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms. Clin Genet. 2013;84(1):20-30. [DOI:10.1111/cge.12056] [PMID]
23. Heliö K, Kangas-Kontio T, Weckström S, Vanninen SUM, Aalto-Setälä K, Alastalo T, et al. DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy. BMC Med Genet. 2020;21(1):19. [DOI:10.1186/s12881-020-0955-z] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Reports of Biochemistry and Molecular Biology

Designed & Developed by : Yektaweb